Danish Centre for Strategic Research in Type 2 Diabetes (DD2) project cohort of newly diagnosed patients with type 2 diabetes: a cohort profile

PURPOSE: The aim of this article is to provide a detailed description of the ongoing nationwide Danish Centre for Strategic Research in Type 2 Diabetes (DD2) project cohort and biobank. The DD2 cohort continuously enrols newly diagnosed patients with type 2 diabetes (T2D) throughout Denmark. The ove...

Descripción completa

Detalles Bibliográficos
Autores principales: Christensen, Diana Hedevang, Nicolaisen, Sia Kromann, Berencsi, Klára, Beck-Nielsen, Henning, Rungby, Jørgen, Friborg, Søren, Brandslund, Ivan, Christiansen, Jens Sandahl, Vaag, Allan, Sørensen, Henrik Toft, Nielsen, Jens Steen, Thomsen, Reimar Wernich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5892767/
https://www.ncbi.nlm.nih.gov/pubmed/29627803
http://dx.doi.org/10.1136/bmjopen-2017-017273
_version_ 1783313211912617984
author Christensen, Diana Hedevang
Nicolaisen, Sia Kromann
Berencsi, Klára
Beck-Nielsen, Henning
Rungby, Jørgen
Friborg, Søren
Brandslund, Ivan
Christiansen, Jens Sandahl
Vaag, Allan
Sørensen, Henrik Toft
Nielsen, Jens Steen
Thomsen, Reimar Wernich
author_facet Christensen, Diana Hedevang
Nicolaisen, Sia Kromann
Berencsi, Klára
Beck-Nielsen, Henning
Rungby, Jørgen
Friborg, Søren
Brandslund, Ivan
Christiansen, Jens Sandahl
Vaag, Allan
Sørensen, Henrik Toft
Nielsen, Jens Steen
Thomsen, Reimar Wernich
author_sort Christensen, Diana Hedevang
collection PubMed
description PURPOSE: The aim of this article is to provide a detailed description of the ongoing nationwide Danish Centre for Strategic Research in Type 2 Diabetes (DD2) project cohort and biobank. The DD2 cohort continuously enrols newly diagnosed patients with type 2 diabetes (T2D) throughout Denmark. The overall goal of the DD2 project is to establish a large and data-rich T2D cohort that can serve as a platform for exhaustive T2D research including (1) improved genotypic and phenotypic characterisation of T2D, (2) intervention studies of more individualised T2D treatment, (3) pharmacoepidemiological studies and (4) long-term follow-up studies on predictors of T2D complications and prognosis. PARTICIPANTS: Between 2010 and 2016, 7011 individuals with T2D have been enrolled and assessed at baseline. Information collected include interview data (eg, body weight at age 20 years, physical activity and alcohol consumption), clinical examination data (eg, hip–waist ratio and resting heart rate) and biological samples (whole blood, DNA, plasma and urine) stored at −80°C and currently analysed for a range of biomarkers and genotypes. FINDINGS TO DATE: Registry linkage has provided extensive supplemental continuous data on glycosylated haemoglobin A, lipids, albuminuria, blood pressure, smoking habits, body mass index, primary care contacts, hospital diagnoses and procedures, medication use, cancer and mortality. Cross-sectional associations between biomarkers, family history, anthropometric and lifestyle measures and presence of complications at baseline have been reported. FUTURE PLANS: During 2016, a detailed follow-up questionnaire has been answered by 85% of initial participants, providing follow-up information on baseline variables and on presence of diabetic neuropathy. The DD2 cohort has now been followed for a total of 18 862 person-years, and nested intervention trials and follow-up studies are ongoing. In the future, the cohort will serve as a strong national and international resource for recruiting patients to nested case studies, clinical trials, postmarketing surveillance, large-scale genome studies and follow-up studies of T2D complications.
format Online
Article
Text
id pubmed-5892767
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-58927672018-04-13 Danish Centre for Strategic Research in Type 2 Diabetes (DD2) project cohort of newly diagnosed patients with type 2 diabetes: a cohort profile Christensen, Diana Hedevang Nicolaisen, Sia Kromann Berencsi, Klára Beck-Nielsen, Henning Rungby, Jørgen Friborg, Søren Brandslund, Ivan Christiansen, Jens Sandahl Vaag, Allan Sørensen, Henrik Toft Nielsen, Jens Steen Thomsen, Reimar Wernich BMJ Open Diabetes and Endocrinology PURPOSE: The aim of this article is to provide a detailed description of the ongoing nationwide Danish Centre for Strategic Research in Type 2 Diabetes (DD2) project cohort and biobank. The DD2 cohort continuously enrols newly diagnosed patients with type 2 diabetes (T2D) throughout Denmark. The overall goal of the DD2 project is to establish a large and data-rich T2D cohort that can serve as a platform for exhaustive T2D research including (1) improved genotypic and phenotypic characterisation of T2D, (2) intervention studies of more individualised T2D treatment, (3) pharmacoepidemiological studies and (4) long-term follow-up studies on predictors of T2D complications and prognosis. PARTICIPANTS: Between 2010 and 2016, 7011 individuals with T2D have been enrolled and assessed at baseline. Information collected include interview data (eg, body weight at age 20 years, physical activity and alcohol consumption), clinical examination data (eg, hip–waist ratio and resting heart rate) and biological samples (whole blood, DNA, plasma and urine) stored at −80°C and currently analysed for a range of biomarkers and genotypes. FINDINGS TO DATE: Registry linkage has provided extensive supplemental continuous data on glycosylated haemoglobin A, lipids, albuminuria, blood pressure, smoking habits, body mass index, primary care contacts, hospital diagnoses and procedures, medication use, cancer and mortality. Cross-sectional associations between biomarkers, family history, anthropometric and lifestyle measures and presence of complications at baseline have been reported. FUTURE PLANS: During 2016, a detailed follow-up questionnaire has been answered by 85% of initial participants, providing follow-up information on baseline variables and on presence of diabetic neuropathy. The DD2 cohort has now been followed for a total of 18 862 person-years, and nested intervention trials and follow-up studies are ongoing. In the future, the cohort will serve as a strong national and international resource for recruiting patients to nested case studies, clinical trials, postmarketing surveillance, large-scale genome studies and follow-up studies of T2D complications. BMJ Publishing Group 2018-04-07 /pmc/articles/PMC5892767/ /pubmed/29627803 http://dx.doi.org/10.1136/bmjopen-2017-017273 Text en © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Diabetes and Endocrinology
Christensen, Diana Hedevang
Nicolaisen, Sia Kromann
Berencsi, Klára
Beck-Nielsen, Henning
Rungby, Jørgen
Friborg, Søren
Brandslund, Ivan
Christiansen, Jens Sandahl
Vaag, Allan
Sørensen, Henrik Toft
Nielsen, Jens Steen
Thomsen, Reimar Wernich
Danish Centre for Strategic Research in Type 2 Diabetes (DD2) project cohort of newly diagnosed patients with type 2 diabetes: a cohort profile
title Danish Centre for Strategic Research in Type 2 Diabetes (DD2) project cohort of newly diagnosed patients with type 2 diabetes: a cohort profile
title_full Danish Centre for Strategic Research in Type 2 Diabetes (DD2) project cohort of newly diagnosed patients with type 2 diabetes: a cohort profile
title_fullStr Danish Centre for Strategic Research in Type 2 Diabetes (DD2) project cohort of newly diagnosed patients with type 2 diabetes: a cohort profile
title_full_unstemmed Danish Centre for Strategic Research in Type 2 Diabetes (DD2) project cohort of newly diagnosed patients with type 2 diabetes: a cohort profile
title_short Danish Centre for Strategic Research in Type 2 Diabetes (DD2) project cohort of newly diagnosed patients with type 2 diabetes: a cohort profile
title_sort danish centre for strategic research in type 2 diabetes (dd2) project cohort of newly diagnosed patients with type 2 diabetes: a cohort profile
topic Diabetes and Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5892767/
https://www.ncbi.nlm.nih.gov/pubmed/29627803
http://dx.doi.org/10.1136/bmjopen-2017-017273
work_keys_str_mv AT christensendianahedevang danishcentreforstrategicresearchintype2diabetesdd2projectcohortofnewlydiagnosedpatientswithtype2diabetesacohortprofile
AT nicolaisensiakromann danishcentreforstrategicresearchintype2diabetesdd2projectcohortofnewlydiagnosedpatientswithtype2diabetesacohortprofile
AT berencsiklara danishcentreforstrategicresearchintype2diabetesdd2projectcohortofnewlydiagnosedpatientswithtype2diabetesacohortprofile
AT becknielsenhenning danishcentreforstrategicresearchintype2diabetesdd2projectcohortofnewlydiagnosedpatientswithtype2diabetesacohortprofile
AT rungbyjørgen danishcentreforstrategicresearchintype2diabetesdd2projectcohortofnewlydiagnosedpatientswithtype2diabetesacohortprofile
AT friborgsøren danishcentreforstrategicresearchintype2diabetesdd2projectcohortofnewlydiagnosedpatientswithtype2diabetesacohortprofile
AT brandslundivan danishcentreforstrategicresearchintype2diabetesdd2projectcohortofnewlydiagnosedpatientswithtype2diabetesacohortprofile
AT christiansenjenssandahl danishcentreforstrategicresearchintype2diabetesdd2projectcohortofnewlydiagnosedpatientswithtype2diabetesacohortprofile
AT vaagallan danishcentreforstrategicresearchintype2diabetesdd2projectcohortofnewlydiagnosedpatientswithtype2diabetesacohortprofile
AT sørensenhenriktoft danishcentreforstrategicresearchintype2diabetesdd2projectcohortofnewlydiagnosedpatientswithtype2diabetesacohortprofile
AT nielsenjenssteen danishcentreforstrategicresearchintype2diabetesdd2projectcohortofnewlydiagnosedpatientswithtype2diabetesacohortprofile
AT thomsenreimarwernich danishcentreforstrategicresearchintype2diabetesdd2projectcohortofnewlydiagnosedpatientswithtype2diabetesacohortprofile